Signal Transduction by PI3K/Akt/mTOR Pathway

通过 PI3K/Akt/mTOR 途径进行信号转导

基本信息

  • 批准号:
    9108384
  • 负责人:
  • 金额:
    $ 30.61万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-07-10 至 2019-04-30
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): The signaling pathway regulated by phosphatidylinositol 3-kinase (PI3K) and the downstream serine/threonine kinase Akt (also known as protein kinase B) transduces the signals encoded by insulin and growth factors and regulates a number of processes that are critical to cell physiology. In addition to serving as a critical downstream component in the PI3K/Akt pathway, the mechanistic target of rapamycin (mTOR) also integrates signals from amino acids, stress, oxygen and energy level to impact most major cellular functions. For such key-node signaling molecules as PI3K, Akt and mTOR, which regulate multiple cellular processes, spatial compartmentalization has been suggested to be an important mechanism for achieving high signaling specificity. In particular, accumulating evidence has suggested that spatial compartmentalization is not only important for enhancing signaling specificity, it is also required for the functioning of the PI3K/Akt/mTOR signaling pathway. However, spatial regulation of PI3K/Akt/mTOR signaling is not well defined and the underlying mechanisms remain poorly understood. The overall goal of our research is to elucidate the molecular and cellular mechanisms by which the PI3K/Akt/mTOR pathway is spatially regulated. We have performed a series of preliminary studies that focus on the plasma membrane and nuclear regulation of this pathway, which led to the hypothesis that signaling activities of the PI3K/Akt/mTOR pathway are present and specifically regulated in both plasma membrane and nuclear compartments. In this proposal, building upon our preliminary findings, we will use NIH3T3 fibroblasts, 3T3 L1 adipocytes, and primary mouse adipocytes as cellular model systems, and combine biochemical and functional characterization with biosensor engineering and super-resolution fluorescence microscopy to address the following aims: 1) To investigate spatial compartmentalization of phosphoinositides.; 2) To examine cellular regulation of Akt; 3) To determine the mechanisms that regulate mTORC1 activities in subcellular compartments. Dysregulated PI3K/Akt/mTOR signaling has widespread implications for clinical conditions. In insulin-responsive tissues, the pathway plays a pivotal role for the effects of insulin, and impaired signaling through PI3K/Akt/mTOR may predispose to the development of diabetes. A mechanistic understanding of signal transduction by PI3K/Akt/mTOR is crucial to developing therapeutic approaches for these clinical conditions.
 描述(由适用提供):由磷脂酰肌醇3-激酶(PI3K)调节的信号通路和下游的串行/苏氨酸激酶Akt(也称为蛋白激酶B)翻译了由胰岛素和生长因子编码的信号,并调节了关键对细胞物理学的过程。除了作为PI3K/AKT途径中的关键下游成分外,雷帕霉素(MTOR)的机械靶标还整合了来自氨基酸,应力,氧气和能级的信号,以影响大多数主要的细胞功能。对于调节多个细胞过程的PI3K,AKT和MTOR(AKT和MTOR)等键节点的信号分子,已经认为空间隔室化是实现高信号特异性的重要机制。特别是,累积的证据被认为,空间隔室不仅对于增强信号特异性很重要,而且PI3K/AKT/MTOR信号通路的功能也是必需的。但是,PI3K/AKT/MTOR信号传导的空间调节尚未很好地定义,并且潜在机制仍然很少了解。我们研究的总体目标是阐明PI3K/AKT/MTOR途径在空间调节的分子和细胞机制。我们已经进行了一系列初步研究,这些研究重点介绍了该途径的质膜和核调节,这导致了以下假设:PI3K/AKT/MTOR途径的信号传导活性在质膜和核隔室中都存在,并特别调节。在这项提议中,基于我们的初步发现,我们将使用NIH3T3成纤维细胞,3T3 L1脂肪细胞和主要的小鼠脂肪细胞作为细胞模型系统,并将生物化学和功能性特征与生物传感器工程和超级分辨率荧光显微镜与下面的ARPATINS:1)进行了调查:1) 2)检查AKT的细胞调节; 3)确定调节亚细胞隔室中MTORC1活性的机制。 PI3K/AKT/MTOR信号传导的失调对临床条件具有宽度的影响。在胰岛素响应的时机中,该途径对胰岛素的作用起着关键作用,并且通过PI3K/AKT/MTOR的信号受损可能会易于发育。 PI3K/AKT/MTOR对信号转导的机械理解对于开发这些临床条件的治疗方法至关重要。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据

数据更新时间:2024-06-01

Jin Zhang的其他基金

Integrating multi-omics, imaging, and longitudinal data to predict radiation response in cervical cancer
整合多组学、成像和纵向数据来预测宫颈癌的放射反应
  • 批准号:
    10734702
    10734702
  • 财政年份:
    2023
  • 资助金额:
    $ 30.61万
    $ 30.61万
  • 项目类别:
HPV genomic structure in cervical cancer radiation response and recurrence detection
HPV基因组结构在宫颈癌放射反应和复发检测中的作用
  • 批准号:
    10634999
    10634999
  • 财政年份:
    2023
  • 资助金额:
    $ 30.61万
    $ 30.61万
  • 项目类别:
Deep learning in cervical cancer radiogenomics
宫颈癌放射基因组学中的深度学习
  • 批准号:
    10643978
    10643978
  • 财政年份:
    2022
  • 资助金额:
    $ 30.61万
    $ 30.61万
  • 项目类别:
Deep learning in cervical cancer radiogenomics
宫颈癌放射基因组学中的深度学习
  • 批准号:
    10424854
    10424854
  • 财政年份:
    2022
  • 资助金额:
    $ 30.61万
    $ 30.61万
  • 项目类别:
HPV alternative splicing in cervical cancer radiation response
HPV选择性剪接在宫颈癌放射反应中的作用
  • 批准号:
    10308435
    10308435
  • 财政年份:
    2020
  • 资助金额:
    $ 30.61万
    $ 30.61万
  • 项目类别:
HPV alternative splicing in cervical cancer radiation response
HPV选择性剪接在宫颈癌放射反应中的作用
  • 批准号:
    9891761
    9891761
  • 财政年份:
    2020
  • 资助金额:
    $ 30.61万
    $ 30.61万
  • 项目类别:
HPV alternative splicing in cervical cancer radiation response
HPV选择性剪接在宫颈癌放射反应中的作用
  • 批准号:
    10523104
    10523104
  • 财政年份:
    2020
  • 资助金额:
    $ 30.61万
    $ 30.61万
  • 项目类别:
FASEB SRC on Protein Kinases and Protein Phosphorylation
FASEB SRC 关于蛋白激酶和蛋白磷酸化
  • 批准号:
    9754337
    9754337
  • 财政年份:
    2019
  • 资助金额:
    $ 30.61万
    $ 30.61万
  • 项目类别:
Live-cell Activity Architecture in Cancer
癌症中的活细胞活性结构
  • 批准号:
    10673027
    10673027
  • 财政年份:
    2015
  • 资助金额:
    $ 30.61万
    $ 30.61万
  • 项目类别:
Live-cell Activity Architecture in Cancer
癌症中的活细胞活性结构
  • 批准号:
    9319218
    9319218
  • 财政年份:
    2015
  • 资助金额:
    $ 30.61万
    $ 30.61万
  • 项目类别:

相似国自然基金

基于3T3-L1细胞和肠道菌群研究荞麦多酚差异性吸收组分调节脂质代谢机制
  • 批准号:
    32302090
  • 批准年份:
    2023
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
四溴双酚A及其替代品促进3T3-L1细胞脂肪形成的作用机制及早期效应标志物研究
  • 批准号:
    42207501
  • 批准年份:
    2022
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
四溴双酚A及其替代品促进3T3-L1细胞脂肪形成的作用机制及早期效应标志物研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
黄花败酱改善3T3-L1脂肪细胞胰岛素抵抗的活性成分及作用机制研究
  • 批准号:
    31900292
  • 批准年份:
    2019
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
黄连温胆汤调控3T3-L1脂肪细胞胰岛素受体后信号通路的机制及其药效物质基础
  • 批准号:
    81573935
  • 批准年份:
    2015
  • 资助金额:
    59.0 万元
  • 项目类别:
    面上项目

相似海外基金

Trimming the fat with small proteins: Micropeptides in adipogenesis
用小蛋白质减少脂肪:脂肪生成中的微肽
  • 批准号:
    10655394
    10655394
  • 财政年份:
    2022
  • 资助金额:
    $ 30.61万
    $ 30.61万
  • 项目类别:
The Role of eIF4G1 and eIF4G2 in Translational Control of Adipogenesis and Obesity
eIF4G1 和 eIF4G2 在脂肪生成和肥胖转化控制中的作用
  • 批准号:
    10625835
    10625835
  • 财政年份:
    2022
  • 资助金额:
    $ 30.61万
    $ 30.61万
  • 项目类别:
The Role of eIF4G1 and eIF4G2 in Translational Control of Adipogenesis and Obesity
eIF4G1 和 eIF4G2 在脂肪生成和肥胖转化控制中的作用
  • 批准号:
    10464460
    10464460
  • 财政年份:
    2022
  • 资助金额:
    $ 30.61万
    $ 30.61万
  • 项目类别:
Mechanisms of Environmental-Mixture Induced Metabolic Disruption
环境混合物引起的代谢紊乱的机制
  • 批准号:
    10225688
    10225688
  • 财政年份:
    2020
  • 资助金额:
    $ 30.61万
    $ 30.61万
  • 项目类别:
Mechanisms of adipocyte loss in laminopathy-induced lipodystrophy in mice and humans
小鼠和人类核纤层病诱导的脂肪营养不良中脂肪细胞损失的机制
  • 批准号:
    10447012
    10447012
  • 财政年份:
    2020
  • 资助金额:
    $ 30.61万
    $ 30.61万
  • 项目类别: